HYPERTENSION DIAGNOSTICS INC /MN·4

Aug 10, 4:42 PM ET

SCHWARTZ MARK N 4

4 · HYPERTENSION DIAGNOSTICS INC /MN · Filed Aug 10, 2004

Insider Transaction Report

Form 4
Period: 2004-08-06
SCHWARTZ MARK N
DirectorCEO
Transactions
  • Conversion

    Common Stock Warrant (right to buy)

    2004-08-06$0.17/sh203,559$34,605203,559 total
    Exercise: $0.17Exp: 2004-11-09Common Stock (407,117 underlying)
  • Conversion

    Series A Preferred Stock Warrant (right to buy)

    2004-08-06$2.04/sh12,800$26,11212,800 total
    Exercise: $2.04Exp: 2004-11-09Series A Preferred Stock (25,600 underlying)
  • Conversion

    Common Stock

    2004-08-06$0.17/sh+203,559$34,605203,559 total
  • Conversion

    Series A Preferred Stock

    2004-08-06$2.04/sh+12,800$26,11212,800 total
    Exercise: $2.04Common Stock (12,800 underlying)
Holdings
  • Common Stock Warrant (right to buy)

    Common Stock (84,681 underlying)
    84,681
  • Series A Preferred Stock Warrant (right to buy)

    Series A Preferred Stock (5,325 underlying)
    5,325
  • Series A Preferred Stock Warrant (right to buy)

    Series A Preferred Stock (4,660 underlying)
    4,660
  • Common Stock Warrant (right to buy)

    Common Stock (325,694 underlying)
    325,694
  • Common Stock Warrant (right to buy)

    Common Stock (284,982 underlying)
    284,982
  • Series A Preferred Stock Warrant (right to buy)

    Series A Preferred Stock (6,656 underlying)
    6,656
  • Series A Preferred Stock Warrant (right to buy)

    Series A Preferred Stock (20,480 underlying)
    20,480
  • Series A Preferred Stock

    Common Stock (6,656 underlying)
    6,656
  • Common Stock Warrant (right to buy)

    Common Stock (105,851 underlying)
    105,851
  • Common Stock

    512,968
  • Series A Preferred Stock

    Common Stock (25,600 underlying)
    25,600
  • Series A Preferred Stock Warrant (right to buy)

    Series A Preferred Stock (17,920 underlying)
    17,920
  • Common Stock Warrant (right to buy)

    Common Stock (74,096 underlying)
    74,096
Footnotes (5)
  • [F1]Previously reported.
  • [F2]See Table I.
  • [F3]The purchase represents reporting person's exercise of the issuer's A-1 Preferred Stock Warrant and A-2 Common Stock Warrant.
  • [F4]Expiration date extended to November 9, 2004; shares issued on August 6, 2004.
  • [F5]Not applicable.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -